NEW YORK – Cytox said on Wednesday that it has garnered CE marking for its GenoScore-Lab genetic risk test for Alzheimer's disease and has launched the test in Europe.
GenoScore-Lab analyzes an individual's genes for more than 100,000 SNPs associated with the risk of developing Alzheimer's disease. According to a company spokesperson, the test runs on a custom Axiom array on the Thermo Fisher Scientific GeneTitan platform.